| | | | | |
AVTX Avalo Therapeutics, Inc. Common Stock | €12,3035 | +4,24 % | €720,20M | €14,96K | |
| €40,9004 | +2,57 % | €719,77M | €4,58K | |
| €17,1843 | +1,39 % | €718,73M | €13,57K | |
EVC Entravision Communication | €7,4338 | +0,63 % | €717,87M | €24,57K | |
ETON Eton Pharmaceutcials, Inc. Common Stock | €24,2668 | +2,32 % | €716,48M | €15,32K | |
| €22,6510 | +2,01 % | €714,88M | €10,13K | |
AMPH Amphastar Pharmaceuticals, Inc. | €16,1114 | +3,51 % | €713,95M | €18,76K | |
MATW Matthews International Corp | €22,1064 | +1,16 % | €711,34M | €3,06K | |
TBPH Theravance Biopharma, Inc. | €13,9201 | +1,79 % | €711,20M | €9,02K | |
MPB Mid Penn Bancorp, Inc. | €27,7113 | +2,38 % | €710,83M | €1,99K | |
KRO Kronos Worldwide, Inc. | €5,9915 | -1,34 % | €710,59M | €12,83K | |
ADAM Adamas Trust, Inc. Common Stock | €7,6331 | +1,09 % | €710,15M | €20,41K | |
CAPL CrossAmerica Partners LP Common units representing limited partner interests | €18,7863 | -0,09 % | €708,58M | €2,21K | |
ROOT Root, Inc. Class A Common Stock | €46,2168 | +2,74 % | €707,74M | €12,61K | |
EOI Eaton Vance Enhanced Equity Income Fund | €17,0340 | +0,20 % | €707,22M | €6,12K | |
